Glycomic Characterization of Induced Pluripotent Stem Cells Derived from a Patient Suffering from Phosphomannomutase 2 Congenital Disorder of Glycosylation (PMM2-CDG)-Reference-Cited by-同舟云学术

Glycomic Characterization of Induced Pluripotent Stem Cells Derived from a Patient Suffering from Phosphomannomutase 2 Congenital Disorder of Glycosylation (PMM2-CDG)

Published:2016-04 Issue:4 Volume:15 Page:1435-1452
ISSN:1535-9476
Container-title:Molecular & Cellular Proteomics
language:en
Short-container-title:Molecular & Cellular Proteomics

Author:

Thiesler Christina T.,Cajic Samanta,Hoffmann Dirk,Thiel Christian,van Diepen Laura,Hennig René,Sgodda Malte,Weiβmann Robert,Reichl Udo,Steinemann Doris,Diekmann Ulf,Huber Nicolas M.B.,Oberbeck Astrid,Cantz Tobias,Kuss Andreas W.,Körner Christian,Schambach Axel,Rapp Erdmann,Buettner Falk F.R.

Publisher

Elsevier BV

Subject

Molecular Biology,Biochemistry,Analytical Chemistry

Reference85 articles.

1. Mutations in PMM2, a phosphomannomutase gene on chromosome 16p13, in carbohydrate-deficient glycoprotein type I syndrome (Jaeken syndrome);Matthijs;Nat. Genet,1997

2. Congenital disorders of glycosylation: an update on defects affecting the biosynthesis of dolichol-linked oligosaccharides;Haeuptle;Hum. Mutat,2009

3. Lack of Hardy-Weinberg equilibrium for the most prevalent PMM2 mutation in CDG-Ia (congenital disorders of glycosylation type Ia);Schollen;Eur. J. Hum. Genet,2000

4. Mutations in PMM2 that cause congenital disorders of glycosylation, type Ia (CDG-Ia);Matthijs;Hum. Mutat,2000

5. The clinical spectrum of phosphomannomutase 2 deficiency (CDG-Ia);Grunewald;Biochim. Biophys. Acta,2009

Cited by 45 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. HepG2 PMM2-CDG knockout model: A versatile platform for variant and therapeutic evaluation;Molecular Genetics and Metabolism;2024-09

2. A complement C4–derived glycopeptide is a biomarker for PMM2-CDG;JCI Insight;2024-04-08

3. Targeting the glycan epitope type I N-acetyllactosamine enables immunodepletion of human pluripotent stem cells from early differentiated cells;Glycobiology;2024-02-13

4. A novel integrated extraction protocol for multi-omic studies in heavily degraded samples;2023-12-15

5. Targeting the glycan epitope type IN-acetyllactosamine enables immunodepletion of human pluripotent stem cells from early differentiated cells;2023-08-30